By MICHAEL MILLENSON Shared decision-making between doctors and patients may be “the pinnacle of patient-centered care,” but three new medical journal articles suggest it’s encountering more problems than peaks. Yet counterintuitively, it may be artificial intelligence that rescues this intimately human interaction. “Shared decision-making is at a crossroads,” declares a Perspective in the Journal of General…
Rural People’s Voice organized a press conference last month to alert the public
Healthcare AI progress could soon stall due to fragmented, inaccessible data systems, warned OMNY Health CEO Mitesh Rao. He said that scalable AI requires a more interoperable data infrastructure — and without it, even it will be difficult for advanced AI solutions to succeed. The post Healthcare’s Poor Data Infrastructure Is Hindering AI Innovation in…
With HealthTap’s new direct virtual primary care program, members get ongoing access to a primary care doctor of their choosing through video visits and messaging. The post HealthTap Introduces Direct Virtual Primary Care Program appeared first on MedCity News.
Hansa Biopharma has encouraging early clinical results showing its drug imlifidase, used as a pretreatment, enabled Duchenne muscular dystrophy patients to receive the gene therapy Elevidys. Sarepta is searching for ways to mitigate excessive immune responses to Elevidys that can lead to serious and potentially fatal liver injury. The post Sarepta’s Future in Gene Therapy…
Today’s AI is not truly agentic because it’s not truly independent of you. The current crop of agents can’t set complex goals, or properly verify outputs. You have to spend a lot of effort on prompting, verifying, and system integrating. That just means the smarter you are, the smarter the AI is. It’s really amplified…
The HHS Secretary contends that federal policy financially rewarded hospitals for reporting staff vaccination rates
Premiums will rise in 2026 for most of the 22 million people who receive premium tax credits, experts say
This data note examines the role that immigrants play in the rural workforce, particularly in industries disproportionately filled by immigrants, including health care, agriculture, construction, and service.
Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction. The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity…